創科(00669.HK)彈近半成 美國2月新房動工量急彈至五個月高遠勝預期
美國2月新屋動工及建築許可量按月分別急漲9.8%及13.8%,以年率計分別增至145萬間及152.4萬間齊創五個月高兼遠勝市場預期。本港藍籌出口股創科實業(00669.HK)繼昨天隨大市回落守穩10天線後,今早股價重越20天線(84.6元)後,最多回升5.7%至88.95元,現報88.1元,回升4.7%,成交304萬股。
港股繼昨天回落至近三個月低位後,今早在科指急彈3.5%主導,最高見19,487,現報19,432,回升228點或1.2%,總成交額478億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.